BFEC
ARKG icon

Benjamin F. Edwards & Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$11K Sell
482
-134
-22% -$3.38K ﹤0.01% 1691
2024
Q1 		$18K Buy
616
+193
+46% +$5.8K ﹤0.01% 1555
2023
Q4 		$14K Hold
423
– – ﹤0.01% 1565
2023
Q3 		$12K Hold
423
– – ﹤0.01% 1345
2023
Q2 		$14K Hold
423
– – ﹤0.01% 1346
2023
Q1 		$13K Hold
423
– – ﹤0.01% 1350
2022
Q4 		$12K Sell
423
-835
-66% -$26.5K ﹤0.01% 1382
2022
Q3 		$41K Buy
1,258
+725
+136% +$26.6K ﹤0.01% 1100
2022
Q2 		$17K Sell
533
-384
-42% -$13.4K ﹤0.01% 1267
2022
Q1 		$42K Sell
917
-1,985
-68% -$94.6K ﹤0.01% 1070
2021
Q4 		$178K Sell
2,902
-326
-10% -$22.5K 0.01% 721
2021
Q3 		$241K Hold
3,228
– – 0.01% 612
2021
Q2 		$299K Sell
3,228
-694
-18% -$59K 0.02% 561
2021
Q1 		$348K Buy
3,922
+201
+5% +$19.9K 0.02% 540
2020
Q4 		$347K Buy
3,721
+2,195
+144% +$175K 0.02% 509
2020
Q3 		$97K Buy
1,526
+999
+190% +$58.5K 0.01% 750
2020
Q2 		$27K Hold
527
– – ﹤0.01% 1030
2020
Q1 		$16K Buy
527
+325
+161% +$10.9K ﹤0.01% 1132
2019
Q4 		$7K Hold
202
– – ﹤0.01% 1503
2019
Q3 		$6K Hold
202
– – ﹤0.01% 1515
2019
Q2 		$7K Hold
202
– – ﹤0.01% 1506
2019
Q1 		$7K Buy
202
+2
+1% +$59 ﹤0.01% 1396
2018
Q4 		$5K Buy
+200
New +$5.64K ﹤0.01% 1432

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $3.3B AUM 33.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Benjamin F. Edwards & Company's ARKG Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q2 2024, selling an estimated $3.38K and leaving 482 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Benjamin F. Edwards & Company first reported a position in ARKG in Q4 2018 and has held it in 23 quarters since. The position peaked at $348K in Q1 2021. 263 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Benjamin F. Edwards & Company held 482 shares of ARK Genomic Revolution ETF worth $11K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 134 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $3.38K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1691 holding.
  • Benjamin F. Edwards & Company first reported a position in ARK Genomic Revolution ETF in Q4 2018 and has held it in 23 quarters since.
  • Benjamin F. Edwards & Company's ARK Genomic Revolution ETF position peaked at $348K in Q1 2021.
  • 263 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.